On Wednesday, the House of Representatives unanimously approved a resolution extending the “right to be forgotten” to patients with certain chronic diseases. According to the House, if the disease is under control, insurers should no longer take this into account in debt stock policies.
Since February 1, 2020, ex-cancer patients have a “right to be forgotten” if they want to take out insurance on their outstanding balance. This means that insurance companies are no longer allowed to take the disease into account once the ten-year treatment has been completed.
However, patients with chronic conditions such as type 1 diabetes will still have to pay an extra premium today if they want to take out insurance on the outstanding balance. House now wants to change that. And it demanded in a decision the right to be forgotten when taking insurance for the balance due to be extended to patients suffering from certain chronic diseases, provided that the disease is under control.
In concrete terms, the House is asking the Federal Healthcare Knowledge Center (KCE) to develop a proposal for eligible chronic diseases. In addition to type 1 diabetes, Parliament is also considering MS, for example. A first start is expected this spring.
Since February 1, 2020, ex-cancer patients have a “right to be forgotten” if they want to take out insurance on their outstanding balance. This means that insurance companies are no longer allowed to take the disease into account once the ten-year treatment has been completed. However, patients with chronic conditions such as type 1 diabetes will still have to pay an extra premium today if they want to take out insurance on the outstanding balance. House now wants to change that. And it demanded in a decision the right to be forgotten when taking insurance for the balance due to be extended to patients suffering from certain chronic diseases, provided that the disease is under control. In concrete terms, the House is asking the Federal Health Care Knowledge Center (KCE) to develop a proposal for eligible chronic diseases. In addition to type 1 diabetes, Parliament is also considering MS, for example. A first start is expected this spring.
